Egle Therapeutics

📍 Paris, France🗓 Founded 2020👥 26 employees💰 Last funded Oct 2021
Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2020
Founded
Investor geography3 countries
France
1
Canada
1
Belgium
1
Frequently asked questions
Who invested in Egle Therapeutics?
Egle Therapeutics has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Egle Therapeutics last raise funding?
The most recent investment in Egle Therapeutics recorded on gritt.io was in October 2021.
When was Egle Therapeutics founded?
Egle Therapeutics was founded in 2020.
What industry is Egle Therapeutics in?
Egle Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Egle Therapeutics based?
Egle Therapeutics is headquartered in Paris, France.